Effect of long-term continuous infusion of alfathesin on clinical biochemical and haematological parameters.
Clinical biochemical and haematological parameters during long-term continuous infusion of alfathesin were studied in twelve neurosurgical patients who did not have multiple organ failure. Significant changes which were possibly caused by alfathesin were an alteration of blood film morphology, an elevation of plasma triglyceride and a reduction in plasma high-density lipids.
D000328:Adult; D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects* / Q000627:therapeutic use; D001809:Blood Viscosity / Q000187:drug effects; D001930:Brain Injuries / Q000601:surgery*; D003422:Critical Care; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006452:Hemoglobinometry; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism; D013345:Subarachnoid Hemorrhage / Q000601:surgery*; D014280:Triglycerides / Q000097:blood
D008075:Lipoproteins, HDL; D012709:Serum Albumin; D014280:Triglycerides; D000530:Alfaxalone Alfadolone Mixture; D005340:Fibrinogen